Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8548, United States.
ACS Chem Neurosci. 2013 Jan 16;4(1):48-63. doi: 10.1021/cn300186b. Epub 2012 Dec 7.
Neuropsychiatric disorders have long been linked to both immune system activation and alterations in serotonin (5-HT) signaling. In the CNS, the contributions of 5-HT modulate a broad range of targets, most notably, hypothalamic, limbic and cortical circuits linked to the control of mood and mood disorders. In the periphery, many are aware of the production and actions of 5-HT in the gut but are unaware that the molecule and its receptors are also present in the immune system where evidence suggests they contribute to the both innate and adaptive responses. In addition, there is clear evidence that the immune system communicates to the brain via both humoral and neuronal mechanisms, and that CNS 5-HT neurons are a direct or indirect target for these actions. Following a brief primer on the immune system, we describe our current understanding of the synthesis, release, and actions of 5-HT in modulating immune function, including the expression of 5-HT biosynthetic enzymes, receptors, and transporters that are typically studied with respect to the roles in the CNS. We then orient our presentation to recent findings that pro-inflammatory cytokines can modulate CNS 5-HT signaling, leading to a conceptualization that among the many roles of 5-HT in the body is an integrated physiological and behavioral response to inflammatory events and pathogens. From this perspective, altered 5-HT/immune conversations are likely to contribute to risk for neurobehavioral disorders historically linked to compromised 5-HT function or ameliorated by 5-HT targeted medications, including depression and anxiety disorders, obsessive-compulsive disorder (OCD), and autism. Our review raises the question as to whether genetic variation impacting 5-HT signaling genes may contribute to maladaptive behavior as much through perturbed immune system modulation as through altered brain mechanisms. Conversely, targeting the immune system for therapeutic development may provide an important opportunity to treat mental illness.
神经精神疾病长期以来一直与免疫系统激活和 5-羟色胺(5-HT)信号改变有关。在中枢神经系统中,5-HT 的贡献调节了广泛的靶点,尤其是与情绪和情绪障碍控制相关的下丘脑、边缘和皮质回路。在外周,许多人都知道 5-HT 在肠道中的产生和作用,但不知道该分子及其受体也存在于免疫系统中,有证据表明它们有助于先天和适应性反应。此外,有明确的证据表明免疫系统通过体液和神经元机制与大脑进行通信,并且中枢神经系统 5-HT 神经元是这些作用的直接或间接靶标。在简要介绍免疫系统之后,我们描述了我们目前对 5-HT 调节免疫功能的合成、释放和作用的理解,包括调节免疫功能的 5-HT 生物合成酶、受体和转运体的表达,这些通常是根据它们在中枢神经系统中的作用来研究的。然后,我们将我们的介绍转向最近的发现,即促炎细胞因子可以调节中枢神经系统 5-HT 信号,从而形成一种概念,即 5-HT 在体内的许多作用之一是对炎症事件和病原体的综合生理和行为反应。从这个角度来看,改变 5-HT/免疫对话可能会导致与 5-HT 功能受损或 5-HT 靶向药物改善相关的神经行为障碍的风险增加,包括抑郁症和焦虑症、强迫症(OCD)和自闭症。我们的综述提出了一个问题,即影响 5-HT 信号基因的遗传变异是否可能通过改变免疫系统调节而不是通过改变大脑机制同样导致适应不良行为。相反,针对免疫系统进行治疗开发可能为治疗精神疾病提供一个重要机会。